Effects of chemopreventive citrus phytochemicals on human P-glycoprotein and multidrug resistance protein 1

European Journal of Pharmacology

Volumn 600, Issue 1-3, 2008, Pages 45-49

  Nabekura, Tomohiro ^a   Yamaki, Takeshi ^a   Kitagawa, Shuji ^b  

^a NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

^b KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

ABC transporter; ABCB1; Citrus phytochemical; MRP1; Multidrug resistance; P glycoprotein

Indexed keywords

ADENOSINE TRIPHOSPHATASE; AURAPTENE; CALCEIN; CITRAL; CITRONELLAL; DAUNORUBICIN; GLYCOPROTEIN P; LIMONENE; LIMONIN; MULTIDRUG RESISTANCE PROTEIN 1; NOBILETIN; OXEDRINE; PLANT MEDICINAL PRODUCT;

ARTICLE; CITRUS FRUIT; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NONHUMAN; ORANGE (FRUIT); PHYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ADENOSINE TRIPHOSPHATASES; ANTIBIOTICS, ANTINEOPLASTIC; CITRUS; DAUNORUBICIN; FLUORESCEINS; FOOD-DRUG INTERACTIONS; HUMANS; KB CELLS; P-GLYCOPROTEIN;

EID: 55949090550     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.10.025     Document Type: Article

References (27)

1. Akiyama S., Fojo A., Hanover J.A., Pastan I., and Gottesman M.M. Isolation and genetic characterization of human KB cell lines resistant to multiple drugs. Somat. Cell Mol. Genet. 11 (1985) 117-126
2. Ambudkar S.V., Dey S., Hrycyna C.A., Ramachandra M., Pastan I., and Gottesman M.M. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu. Rev. Pharmacol. Toxicol. 39 (1999) 361-368
3. Borst P., and Oude Elfenik R. Mammalian ABC transporters in health and disease. Annu. Rev. Biochem. 71 (2002) 537-592
4. Dahan A., and Altman H. Food-drug interaction: grapefruit juice augments drug bioavailability - mechanism, extent and relevance. Eur. J. Clin. Nutr. 58 (2004) 1-9
5. Dorai T., and Aggarwal B.B. Role of chemopreventive agents in cancer therapy. Cancer Lett. 215 (2004) 129-140
6. Endres C.J., Hsiao P., Chung F.S., and Unadkat J.D. The role of transporters in drug interactions. Eur. J. Pharm. Sci. 27 (2006) 501-507
7. Ju-ichi M. Chemical study of Citrus plants in the search for cancer chemopreventive agents. Yakugaku Zasshi 125 (2005) 231-254
8. Kawaii S., Tomono Y., Katase E., Ogawa K., and Yano M. HL-60 differentiating activity and flavonid content of the readily extractable fraction prepared from citrus juices. J. Agric. Food Chem. 47 (1999) 128-135
9. Kitagawa S., Nabekura T., and Kamiyama S. Inhibition of P-glycoprotein function by tea catechins in KB-C2 cells. J. Pharm. Pharmacol. 56 (2004) 1001-1005
10. Kitagawa S., Nabekura T., Kamiyama S., Takahashi T., Nakamura Y., Kashiwada Y., and Ikeshiro Y. Effects alkyl gallates on P-glycoprotein function. Biochem. Pharmacol. 70 (2005) 1262-1266
11. Kitagawa S., Nabekura T., Takahashi T., Nakamura Y., Sakamoto H., Tano H., Hirai M., and Tsukahara G. Structure-activity relationships of the inhibitory effects of flavonoids on P-glycoprotein-mediated transport in KB-C2 cells. Biol. Pharm. Bull. 28 (2005) 2274-2278
12. Leslie E.M., Mao Q., Oleschuk C.J., Deeley R.G., and Cole S.P.C. Modulation of multidrug resistance protein 1 (MRP1/ABCC1) transport and ATPase activities by interaction with dietary flavonoids. Mol. Pharmacol. 59 (2001) 1171-1180
13. Mouly P., Gaydou E.M., and Auffray A. Simultaneous separation of flavanone glycosides and polymethoxylated flavones in citrus juices using liquid chromatography. J. Chromatogr. A. 800 (1998) 171-179
14. Murakami A., Kuki W., Takahashi Y., Yonei H., Nakamura Y., Ohto Y., Ohigashi H., and Koshimizu K. Auraptene, a citrus coumarin, inhibits 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion in ICR mouse skin, possibly through suppression of superoxide generation in leukocytes. Jpn. J. Cancer Res. 88 (1997) 443-452
15. Murakami A., Nakamura Y., Tanaka T., Kawabata K., Takahashi D., Koshimizu K., and Ohigashi H. Suppression by citrus auraptene of phorbol ester- and endotoxin-induced inflammatory responses: role of attenuation of leukocyte activation. Carcinogenesis 21 (2000) 1843-1850
16. Murakami A., Nakamura Y., Torikai K., Tanaka T., Koshiba T., Koshimizu K., Kuwahara S., Takahashi Y., Ogawa K., Yano M., Tokuda H., Nishino H., Mimaki Y., Sashida Y., Kitanaka S., and Ohigashi H. Inhibitory effect of citrus nobiletin on phorbol ester-induced skin inflammation, oxidative stress, and tumor promotion in mice. Cancer Res. 60 (2000) 5059-5066
17. Nabekura T., Kamiyama S., and Kitagawa S. Effects of dietary chemopreventive phytochemicals on P-glycoprotein function. Biochem. Biophys. Res. Commun. 327 (2005) 866-870
18. Okumura H., Chen Z.-S., Sakou M., Sumizawa T., Furukawa T., Komatsu M., Ikeda R., Suzuki H., Hirota K., Aikou T., and Akiyama S.-i. Reversal of P-glycoprotein and multidrug-resistance protein-mediated drug resistance in KB cells by 5-O-benzoylated taxinine. K. Mol. Pharmacol. 58 (2000) 1563-1569
19. Roninson I.B., Chin J.E., Choi K.G., Gros P., Housman D.E., Fojo A., Shen D.W., Gottesman M.M., and Pastan I. Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells. Proc. Natl. Acad. Sci. U.S.A. 83 (1986) 4538-4542
20. Sarkadi B., Price E.M., Boucher R.C., Germann U.A., and Scarborough G.A. Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase. J. Biol. Chem. 267 (1992) 4854-4858
21. Surh Y.-J. Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer 3 (2003) 768-780
22. Taguchi Y., Yoshida A., Takada Y., Komano T., and Ueda K. Anti-cancer drugs and glutathione stimulate vanadate-induced trapping of nucleotide in multidrug resistance -associated protein (MRP). FEBS Lett. 401 (1997) 11-14
23. Takanaga H., Ohnishi A., Yamada S., Matsuo H., Morimoto S., Shoyama Y., Ohtani H., and Sawada Y. Polymethoxylated flavones in orange juice are inhibitors of P-glycoprotein but not cytochrome P450 3A4. J. Pharmacol. Exp. Ther. 293 (2000) 230-236
24. Tanaka T., Kawabata K., Kakumoto M., Makita H., Hara A., Mori H., Satoh K., Hara A., Murakami A., Kuki W., Takahashi Y., Yonei H., Koshimizu K., and Ohigashi H. Citrus auraptene inhibits chemically induced colonic aberrant crypt foci in male F344 rats. Carcinogenesis 18 (1997) 2155-2161
25. Tanaka T., Kawabata K., Kakumoto M., Matsunaga K., Mori H., Murakami A., Kuki W., Takahashi Y., Yonei H., Satoh K., Hara A., Maeda M., Ota T., Odashima S., Koshimizu K., and Ohigashi H. Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by citrus auraptene in rats. Carcinogenesis 19 (1998) 425-431
26. Tang M.-X., Ogawa K., Asamoto M., Hokaiwado N., Seeni A., Suzuki S., Takahashi S., Tanaka T., Ichikawa K., and Shirai T. Protective effects of citrus nobiletin and auraptene in transgenic rats developing adenocarcinoma of the prostate (TRAP) and human prostate carcinoma cells. Cancer Sci. 98 (2007) 471-477
27. Wortelboer H.M., Usta M., van Zanden J.J., van Bladeren P.J., Rietjens I.M.C.M., and Cnubben N.H.P. Inhibition of multidrug resistance proteins MRP1 and MRP2 by a series of α,β-unsaturated carbonyl compounds. Biochem. Pharmacol. 69 (2005) 1879-1890